YU49313B - Lipozomni preparat koji sadrži selegilin i/ili njegovu so - Google Patents

Lipozomni preparat koji sadrži selegilin i/ili njegovu so

Info

Publication number
YU49313B
YU49313B YU67195A YU67195A YU49313B YU 49313 B YU49313 B YU 49313B YU 67195 A YU67195 A YU 67195A YU 67195 A YU67195 A YU 67195A YU 49313 B YU49313 B YU 49313B
Authority
YU
Yugoslavia
Prior art keywords
weight
salt
pct
liposomic
composition
Prior art date
Application number
YU67195A
Other languages
English (en)
Other versions
YU67195A (sh
Inventor
Michael Mezei
Gaál József
Székács Gábor
Szebeni Gyula
Mármarosi Katalin
Magyar Kálmán
Lengyel József
Szatmári István
Turi Ágnes
Original Assignee
Chinoin Gyógyszer és Vegyészeti Termékek Gyára Rt.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyógyszer és Vegyészeti Termékek Gyára Rt. filed Critical Chinoin Gyógyszer és Vegyészeti Termékek Gyára Rt.
Publication of YU67195A publication Critical patent/YU67195A/sh
Publication of YU49313B publication Critical patent/YU49313B/sh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Abstract

Lipozomni preparat, naznačen time, što sadrži kao aktivni sastojak (-)-N-alfa-dimetil-N-(2-propinilfeniletilamin) (selegilin) i/ili njegovu so. Prijava sadrži još jedan nezavisan i osam zavisnih patentnih zahteva.
YU67195A 1994-10-24 1995-10-25 Lipozomni preparat koji sadrži selegilin i/ili njegovu so YU49313B (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU9403073A HU223475B1 (hu) 1994-10-24 1994-10-24 Selegilint tartalmazó liposzoma-készítmény és eljárás ennek előállítására

Publications (2)

Publication Number Publication Date
YU67195A YU67195A (sh) 1998-07-10
YU49313B true YU49313B (sh) 2005-06-10

Family

ID=10985697

Family Applications (1)

Application Number Title Priority Date Filing Date
YU67195A YU49313B (sh) 1994-10-24 1995-10-25 Lipozomni preparat koji sadrži selegilin i/ili njegovu so

Country Status (30)

Country Link
US (1) US5888536A (sh)
EP (1) EP0788349B1 (sh)
JP (1) JPH10507749A (sh)
KR (1) KR100313149B1 (sh)
CN (1) CN1084186C (sh)
AT (1) ATE205387T1 (sh)
AU (1) AU691348B2 (sh)
BG (1) BG63327B1 (sh)
BR (1) BR9509517A (sh)
CA (1) CA2203513C (sh)
CZ (1) CZ287349B6 (sh)
DE (1) DE69522701T2 (sh)
DK (1) DK0788349T3 (sh)
EE (1) EE03418B1 (sh)
ES (1) ES2160718T3 (sh)
FI (1) FI971743A0 (sh)
HU (1) HU223475B1 (sh)
IL (1) IL115754A (sh)
NO (1) NO316354B1 (sh)
NZ (1) NZ294660A (sh)
PL (1) PL183104B1 (sh)
PT (1) PT788349E (sh)
RO (1) RO116768B1 (sh)
RU (1) RU2159106C2 (sh)
SK (1) SK281599B6 (sh)
TW (1) TW412420B (sh)
UA (1) UA44289C2 (sh)
WO (1) WO1996012472A1 (sh)
YU (1) YU49313B (sh)
ZA (1) ZA958999B (sh)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1052983A2 (en) * 1998-01-27 2000-11-22 Thomas N. Thomas Use of an mao-a or mao-b inhibitor for the treatment of vascular disorders
DE19814257A1 (de) 1998-03-31 1999-10-07 Asta Medica Ag Brauseformulierungen
GB9815785D0 (en) * 1998-07-20 1998-09-16 Cerebrus Ltd Chemical compounds
CN1849112B (zh) * 2003-09-09 2012-06-13 吉里德科学公司 治疗性脂质体
EP1848541A4 (en) * 2005-02-07 2013-01-16 Pharmalight Inc METHOD AND DEVICE FOR OPHTHALMIC DELIVERY OF PHARMACEUTICALLY ACTIVE INGREDIENTS
CN1813679A (zh) * 2005-11-30 2006-08-09 上海医药(集团)有限公司 一种紫杉烷脂质体冻干组合物及其制备方法
US9445975B2 (en) * 2008-10-03 2016-09-20 Access Business Group International, Llc Composition and method for preparing stable unilamellar liposomal suspension
JP5623102B2 (ja) * 2010-03-12 2014-11-12 株式会社フジモト・コーポレーション セレギリン含有貼付製剤
JP5693026B2 (ja) * 2010-03-12 2015-04-01 株式会社フジモト・コーポレーション セレギリン含有貼付製剤
CA2871820C (en) 2012-05-10 2020-11-03 Painreform Ltd. Depot formulations of a hydrophobic active ingredient and methods for preparation thereof
AU2015326378B2 (en) * 2014-09-29 2021-01-21 Council Of Scientific & Industrial Research A formulation useful for delivery of neuro protecting agent
US11426349B2 (en) * 2017-03-23 2022-08-30 Lipid Systems Sp. Z.O.O. High-efficiency encapsulation of hydrophilic compounds in unilamellar liposomes

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH588887A5 (sh) * 1974-07-19 1977-06-15 Battelle Memorial Institute
US4485054A (en) * 1982-10-04 1984-11-27 Lipoderm Pharmaceuticals Limited Method of encapsulating biologically active materials in multilamellar lipid vesicles (MLV)
US4761288A (en) * 1984-09-24 1988-08-02 Mezei Associates Limited Multiphase liposomal drug delivery system
GB8807504D0 (en) * 1988-03-29 1988-05-05 Sandoz Ltd Improvements in/relating to organic compounds
US4937078A (en) * 1988-08-26 1990-06-26 Mezei Associates Limited Liposomal local anesthetic and analgesic products
FR2713087B1 (fr) * 1993-11-30 1996-02-23 Saurat Jean Hilaire Utilisation de la sélégiline et ses dérivés pour la préparation d'un médicament destiné au traitement du psoriasis.

Also Published As

Publication number Publication date
HU9403073D0 (en) 1994-12-28
WO1996012472A1 (en) 1996-05-02
KR970706797A (ko) 1997-12-01
RU2159106C2 (ru) 2000-11-20
EP0788349A1 (en) 1997-08-13
EE03418B1 (et) 2001-06-15
YU67195A (sh) 1998-07-10
EE9700102A (et) 1997-10-15
FI971743A (fi) 1997-04-23
NO971870L (no) 1997-06-24
HU223475B1 (hu) 2004-07-28
ES2160718T3 (es) 2001-11-16
PL319875A1 (en) 1997-09-01
BG63327B1 (bg) 2001-10-31
US5888536A (en) 1999-03-30
ZA958999B (en) 1996-05-15
PL183104B1 (pl) 2002-05-31
CA2203513A1 (en) 1996-05-02
SK281599B6 (sk) 2001-05-10
RO116768B1 (ro) 2001-06-29
DE69522701D1 (de) 2001-10-18
KR100313149B1 (ko) 2002-02-19
CN1163563A (zh) 1997-10-29
NZ294660A (en) 1998-05-27
DK0788349T3 (da) 2001-11-26
FI971743A0 (fi) 1997-04-23
CA2203513C (en) 2001-10-09
NO971870D0 (no) 1997-04-23
NO316354B1 (no) 2004-01-19
TW412420B (en) 2000-11-21
CN1084186C (zh) 2002-05-08
AU691348B2 (en) 1998-05-14
MX9703019A (es) 1997-10-31
EP0788349B1 (en) 2001-09-12
ATE205387T1 (de) 2001-09-15
BG101432A (en) 1997-12-30
BR9509517A (pt) 1997-12-30
HUT76053A (en) 1997-06-30
PT788349E (pt) 2001-12-28
DE69522701T2 (de) 2002-07-11
IL115754A0 (en) 1996-01-19
CZ287349B6 (en) 2000-10-11
UA44289C2 (uk) 2002-02-15
JPH10507749A (ja) 1998-07-28
AU3751895A (en) 1996-05-15
IL115754A (en) 1999-07-14
SK51797A3 (en) 1997-11-05
CZ114797A3 (en) 1997-10-15

Similar Documents

Publication Publication Date Title
ES2301189T3 (es) Agentes de limpieza antimicrobianos.
GR3036772T3 (en) Topically applied pharmaceutical composition, method of preparing it and its use
YU49313B (sh) Lipozomni preparat koji sadrži selegilin i/ili njegovu so
JP2002003364A (ja) 点眼剤、眼科用組成物及び吸着抑制方法
JP3142842B1 (ja) 眼科用組成物及びソフトコンタクトレンズへの吸着抑制方法
JP2018188486A (ja) 非イオン性シリコーンハイドロゲルコンタクトレンズ用点眼剤
JP3175742B1 (ja) コンタクトレンズ用眼科用組成物
JP3734521B2 (ja) 点眼製剤
JP2001253822A (ja) 角膜細胞回復剤組成物
JP4801300B2 (ja) 外用液状組成物
GB2100599A (en) Pharmaceutical preparation for treating glaucoma and ocular hypertension
JP2002104971A (ja) 眼科用組成物
EP1539084B1 (en) Method for treating soft nails
JP2002338476A (ja) 腎透析に伴う痒みの予防治療剤
JP2024006961A (ja) オートファジー活性化剤及びオートファジー活性低下抑制方法
JPH11180872A (ja) 骨代謝改善剤
JPH1129461A (ja) ヒドロキシアスパラギン酸を含有する皮膚外用剤